Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 8,271,449 $ 7,150,695
Prepaid expenses and other current assets 272,583 268,677
Australia research and development incentives receivable 155,969 144,680
Total current assets 8,700,001 7,564,052
Deferred offering costs 13,235 0
Other assets 2,800 2,800
Total assets 8,716,036 7,566,852
Current liabilities:    
Accounts payable 1,872,502 1,638,546
Accrued expenses 3,035,265 3,298,607
Total current liabilities 4,907,767 4,937,153
Long term liabilities:    
Warrant liability 9,573,197 2,152,188
Total liabilities 14,480,964 7,089,341
Commitments and contingencies (Note 7)
Stockholders' equity (deficit)    
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at March 31, 2024 and December 31, 2023, 0 shares issued and outstanding
Common stock, $0.0001 par value, 70,000,000 shares authorized at March 31, 2024 and December 31, 2023, 20,581,469 and 16,986,254 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 2,059 1,699
Additional paid-in capital 66,310,691 64,472,249
Accumulated deficit (72,047,632) (63,980,177)
Accumulated other comprehensive loss (30,046) (16,260)
Total stockholders' equity (deficit) (5,764,928) 477,511
Total liabilities and stockholders' equity (deficit) $ 8,716,036 $ 7,566,852